THE LATEST WORD

Top Industry Stories – November 24, 2009

Posted on November 24th, 2009 | by Rxmedyn | No Comments »

  • Cephalon/Ception Deal Focus Turns To Asthma After A Phase II/III Trial Disappoints (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register. Prevnar 13’s Added Strains,

  • Extra Studies Help Insulate Pfizer’s U.S. Position (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Leave a Reply

You must be logged in to post a comment.